Literature DB >> 17446857

Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer.

Karen T Liby1, Mark M Yore, Michael B Sporn.   

Abstract

Synthetic oleanane triterpenoids and rexinoids are two new classes of multifunctional drugs. They are neither conventional cytotoxic agents, nor are they monofunctional drugs that uniquely target single steps in signal transduction pathways. Synthetic oleanane triterpenoids have profound effects on inflammation and the redox state of cells and tissues, as well as being potent anti-proliferative and pro-apoptotic agents. Rexinoids are ligands for the nuclear receptor transcription factors known as retinoid X receptors. Both classes of agents can prevent and treat cancer in experimental animals. These drugs have unique molecular and cellular mechanisms of action and might prove to be synergistic with standard anti-cancer treatments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17446857     DOI: 10.1038/nrc2129

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  217 in total

1.  Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.

Authors:  Yasuhiro Nakagami; Kayoko Masuda; Emiko Hatano; Tatsuya Inoue; Takuya Matsuyama; Mayumi Iizuka; Yasunori Ono; Takashi Ohnuki; Yoko Murakami; Masaru Iwasaki; Kazuhiro Yoshida; Yuji Kasuya; Satoshi Komoriya
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.

Authors:  Nisha R Parikh; Animesh Mandal; Deepak Bhatia; Kodappully Sivaraman Siveen; Gautam Sethi; Anupam Bishayee
Journal:  Phytochem Rev       Date:  2014-12       Impact factor: 5.374

3.  CDDO-methyl ester delays breast cancer development in BRCA1-mutated mice.

Authors:  Eun-Hee Kim; Chuxia Deng; Michael B Sporn; Darlene B Royce; Renee Risingsong; Charlotte R Williams; Karen T Liby
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-20

Review 4.  How does the macula protect itself from oxidative stress?

Authors:  James T Handa
Journal:  Mol Aspects Med       Date:  2012-04-05

Review 5.  Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

Authors:  Magali Dumont; Michael T Lin; M Flint Beal
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 6.  Neuroprotective strategies involving ROS in Alzheimer disease.

Authors:  Magali Dumont; M Flint Beal
Journal:  Free Radic Biol Med       Date:  2010-12-01       Impact factor: 7.376

7.  Exploration of the antiplatelet activity profile of betulinic acid on human platelets.

Authors:  Andreas G Tzakos; Vassiliki G Kontogianni; Maria Tsoumani; Eleni Kyriakou; John Hwa; Francisco A Rodrigues; Alexandros D Tselepis
Journal:  J Agric Food Chem       Date:  2012-07-03       Impact factor: 5.279

8.  Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia.

Authors:  Twee Tsao; Steven Kornblau; Stephen Safe; Julie C Watt; Vivian Ruvolo; Wenjing Chen; Yihua Qiu; Kevin R Coombes; Zhenlin Ju; Maen Abdelrahim; Wendy Schober; Xiaoyang Ling; Dimitris Kardassis; Colin Meyer; Aaron Schimmer; Hagop Kantarjian; Michael Andreeff; Marina Konopleva
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 9.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 10.  Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.

Authors:  Christina Y Yim; Pingping Mao; Michael J Spinella
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.